ebomi
Colour theme
Sign in
Insider · CIK 0001298033

Domain Partners VI, L.P.

CIK 0001298033 Name as filed on the most recent filing

Filed as Domain Partners VI, L.P. (33)

56 transaction lines · from 33 filings · filed 2010-04-27 to 2016-08-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

4 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-08-03 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 660,916, disposed Open Form 4 filing 0000904454-16-001352
2016-08-02 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 171,744, disposed Open Form 4 filing 0000904454-16-001352
2016-08-01 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 460,545, disposed Open Form 4 filing 0000904454-16-001352
2016-04-28 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 1,042,364, disposed Open Form 4 filing 0000904454-16-001196
2014-08-05 P, Open-market purchase Marinus Pharmaceuticals IncMRNS 3,357,952, acquired Open Form 4 filing 0000904454-14-000567
2014-01-16 S, Open-market sale Alimera Sciences IncALIM 1,340,306, disposed Open Form 4 filing 0000904454-14-000083
2014-01-15 S, Open-market sale Alimera Sciences IncALIM 555,594, disposed Open Form 4 filing 0000904454-14-000083
2013-08-27 P, Open-market purchase Regado Biosciences IncRGDO 3,000,000, acquired Open Form 4 filing 0000904454-13-000985
2013-07-15 P, Open-market purchase Ocera Therapeutics, Inc.OCRX 1,999,999, acquired Open Form 4 filing 0000904454-13-000863
2013-07-15 P, Open-market purchase Ocera Therapeutics, Inc.OCRX 1,999,999, acquired Open Form 4 filing 0000904454-13-000826
2013-06-20 S, Open-market sale Alimera Sciences IncALIM 52,685, disposed Open Form 4 filing 0000904454-13-000715
2013-06-19 S, Open-market sale Alimera Sciences IncALIM 120,412, disposed Open Form 4 filing 0000904454-13-000711
2013-06-18 S, Open-market sale Alimera Sciences IncALIM 177,417, disposed Open Form 4 filing 0000904454-13-000711
2013-06-17 S, Open-market sale Alimera Sciences IncALIM 474,185, disposed Open Form 4 filing 0000904454-13-000701
2013-06-14 S, Open-market sale Alimera Sciences IncALIM 195,652, disposed Open Form 4 filing 0000904454-13-000701
2013-06-11 S, Open-market sale Alimera Sciences IncALIM 26,685, disposed Open Form 4 filing 0000904454-13-000689
2013-05-16 S, Open-market sale Alimera Sciences IncALIM 95,742, disposed Open Form 4 filing 0000904454-13-000582
2013-05-15 S, Open-market sale Alimera Sciences IncALIM 107,940, disposed Open Form 4 filing 0000904454-13-000582
2013-04-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 473,846, disposed Open Form 4 filing 0000904454-13-000492
2013-04-10 S, Open-market sale Cadence Pharmaceuticals IncCADX 32,471, disposed Open Form 4 filing 0000904454-13-000488
2013-04-09 S, Open-market sale Cadence Pharmaceuticals IncCADX 235,615, disposed Open Form 4 filing 0000904454-13-000488
2013-04-08 S, Open-market sale Cadence Pharmaceuticals IncCADX 245,648, disposed Open Form 4 filing 0000904454-13-000488
2013-03-21 S, Open-market sale Cadence Pharmaceuticals IncCADX 72,172, disposed Open Form 4 filing 0000904454-13-000471
2013-03-20 S, Open-market sale Cadence Pharmaceuticals IncCADX 88,714, disposed Open Form 4 filing 0000904454-13-000457
2013-03-19 S, Open-market sale Cadence Pharmaceuticals IncCADX 126,854, disposed Open Form 4 filing 0000904454-13-000457
2013-03-18 S, Open-market sale Cadence Pharmaceuticals IncCADX 127,638, disposed Open Form 4 filing 0000904454-13-000447
2013-03-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 156,916, disposed Open Form 4 filing 0000904454-13-000447
2013-03-14 S, Open-market sale Cadence Pharmaceuticals IncCADX 82,973, disposed Open Form 4 filing 0000904454-13-000437
2013-03-13 S, Open-market sale Cadence Pharmaceuticals IncCADX 128,779, disposed Open Form 4 filing 0000904454-13-000437
2013-03-12 S, Open-market sale Cadence Pharmaceuticals IncCADX 105,281, disposed Open Form 4 filing 0000904454-13-000429
2013-03-11 S, Open-market sale Cadence Pharmaceuticals IncCADX 67,818, disposed Open Form 4 filing 0000904454-13-000429
2013-03-08 S, Open-market sale Cadence Pharmaceuticals IncCADX 84,545, disposed Open Form 4 filing 0000904454-13-000401
2013-03-07 S, Open-market sale Cadence Pharmaceuticals IncCADX 204,457, disposed Open Form 4 filing 0000904454-13-000401
2013-03-06 S, Open-market sale Cadence Pharmaceuticals IncCADX 59,915, disposed Open Form 4 filing 0000904454-13-000397
2013-03-05 S, Open-market sale Cadence Pharmaceuticals IncCADX 62,395, disposed Open Form 4 filing 0000904454-13-000397
2013-03-04 S, Open-market sale Cadence Pharmaceuticals IncCADX 79,484, disposed Open Form 4 filing 0000904454-13-000374
2013-03-01 S, Open-market sale Cadence Pharmaceuticals IncCADX 117,975, disposed Open Form 4 filing 0000904454-13-000374
2013-02-20 S, Open-market sale Cadence Pharmaceuticals IncCADX 30,862, disposed Open Form 4 filing 0000904454-13-000321
2013-02-19 S, Open-market sale Cadence Pharmaceuticals IncCADX 155,997, disposed Open Form 4 filing 0000904454-13-000307
2013-02-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 45,740, disposed Open Form 4 filing 0000904454-13-000307
2013-02-14 S, Open-market sale Cadence Pharmaceuticals IncCADX 45,591, disposed Open Form 4 filing 0000904454-13-000293
2013-02-13 S, Open-market sale Cadence Pharmaceuticals IncCADX 88,850, disposed Open Form 4 filing 0000904454-13-000293
2013-02-01 S, Open-market sale Cadence Pharmaceuticals IncCADX 146,150, disposed Open Form 4 filing 0000904454-13-000165
2013-01-31 S, Open-market sale Cadence Pharmaceuticals IncCADX 269,247, disposed Open Form 4 filing 0000904454-13-000154
2013-01-30 S, Open-market sale Cadence Pharmaceuticals IncCADX 171,240, disposed Open Form 4 filing 0000904454-13-000154
2013-01-29 S, Open-market sale Cadence Pharmaceuticals IncCADX 248,992, disposed Open Form 4 filing 0000904454-13-000142
2013-01-28 S, Open-market sale Cadence Pharmaceuticals IncCADX 277,436, disposed Open Form 4 filing 0000904454-13-000142
2013-01-25 S, Open-market sale Cadence Pharmaceuticals IncCADX 228,785, disposed Open Form 4 filing 0000904454-13-000134
2013-01-25 S, Open-market sale Cadence Pharmaceuticals IncCADX 228,785, disposed Open Form 4 filing 0000904454-13-000130
2013-01-24 S, Open-market sale Cadence Pharmaceuticals IncCADX 610,520, disposed Open Form 4 filing 0000904454-13-000134

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Domain Partners VI, L.P., insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001298033

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.